Global Antimalarial Medication Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

January 2023 | 94 pages | ID: G42E3198507GEN
GlobalInfoResearch

Abstracts

Malaria is a life-threatening disease caused by parasites which are transmitted to people through the bite of an infected female anopheles mosquitoes. This disease is preventable and curable. Humans are infected by four recognized species of malarial parasites, namely, Plasmodium falciparum, P. vivax, P. ovale, and P. malariae.

According to our (Global Info Research) latest study, the global Antimalarial Medication market size was valued at USD 1380.2 million in 2022 and is forecast to a readjusted size of USD 1839.9 million by 2029 with a CAGR of 4.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Antimalarial medication are the medicines used to prevent and treat malaria.

This report is a detailed and comprehensive analysis for global Antimalarial Medication market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Antimalarial Medication market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Antimalarial Medication market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Antimalarial Medication market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029

Global Antimalarial Medication market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Antimalarial Medication

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Antimalarial Medication market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, F. Hoffmann-La Roche, Novartis, Pfizer and Sun Pharmaceutical Industries and etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Antimalarial Medication market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

• Plasmodium Falciparum
• Plasmodium Malariae
• Plasmodium Vivax
• Plasmodium Ovale

Market segment by Application

• Hospital Pharmacy
• Retail Pharmacy
• E- Commerce
• Others

Major players covered

• GlaxoSmithKline
• F. Hoffmann-La Roche
• Novartis
• Pfizer
• Sun Pharmaceutical Industries
• Merck

Market segment by region, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Antimalarial Medication product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Antimalarial Medication, with price, sales, revenue and global market share of Antimalarial Medication from 2018 to 2023.

Chapter 3, the Antimalarial Medication competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Antimalarial Medication breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antimalarial Medication market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Antimalarial Medication.

Chapter 14 and 15, to describe Antimalarial Medication sales channel, distributors, customers, research findings and conclusion.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Antimalarial Medication
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Antimalarial Medication Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Plasmodium Falciparum
  1.3.3 Plasmodium Malariae
  1.3.4 Plasmodium Vivax
  1.3.5 Plasmodium Ovale
1.4 Market Analysis by Application
  1.4.1 Overview: Global Antimalarial Medication Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Hospital Pharmacy
  1.4.3 Retail Pharmacy
  1.4.4 E- Commerce
  1.4.5 Others
1.5 Global Antimalarial Medication Market Size & Forecast
  1.5.1 Global Antimalarial Medication Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Antimalarial Medication Sales Quantity (2018-2029)
  1.5.3 Global Antimalarial Medication Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 GlaxoSmithKline
  2.1.1 GlaxoSmithKline Details
  2.1.2 GlaxoSmithKline Major Business
  2.1.3 GlaxoSmithKline Antimalarial Medication Product and Services
  2.1.4 GlaxoSmithKline Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 F. Hoffmann-La Roche
  2.2.1 F. Hoffmann-La Roche Details
  2.2.2 F. Hoffmann-La Roche Major Business
  2.2.3 F. Hoffmann-La Roche Antimalarial Medication Product and Services
  2.2.4 F. Hoffmann-La Roche Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 F. Hoffmann-La Roche Recent Developments/Updates
2.3 Novartis
  2.3.1 Novartis Details
  2.3.2 Novartis Major Business
  2.3.3 Novartis Antimalarial Medication Product and Services
  2.3.4 Novartis Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Novartis Recent Developments/Updates
2.4 Pfizer
  2.4.1 Pfizer Details
  2.4.2 Pfizer Major Business
  2.4.3 Pfizer Antimalarial Medication Product and Services
  2.4.4 Pfizer Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Pfizer Recent Developments/Updates
2.5 Sun Pharmaceutical Industries
  2.5.1 Sun Pharmaceutical Industries Details
  2.5.2 Sun Pharmaceutical Industries Major Business
  2.5.3 Sun Pharmaceutical Industries Antimalarial Medication Product and Services
  2.5.4 Sun Pharmaceutical Industries Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
2.6 Merck
  2.6.1 Merck Details
  2.6.2 Merck Major Business
  2.6.3 Merck Antimalarial Medication Product and Services
  2.6.4 Merck Antimalarial Medication Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Merck Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: ANTIMALARIAL MEDICATION BY MANUFACTURER

3.1 Global Antimalarial Medication Sales Quantity by Manufacturer (2018-2023)
3.2 Global Antimalarial Medication Revenue by Manufacturer (2018-2023)
3.3 Global Antimalarial Medication Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Antimalarial Medication by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Antimalarial Medication Manufacturer Market Share in 2022
  3.4.2 Top 6 Antimalarial Medication Manufacturer Market Share in 2022
3.5 Antimalarial Medication Market: Overall Company Footprint Analysis
  3.5.1 Antimalarial Medication Market: Region Footprint
  3.5.2 Antimalarial Medication Market: Company Product Type Footprint
  3.5.3 Antimalarial Medication Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Antimalarial Medication Market Size by Region
  4.1.1 Global Antimalarial Medication Sales Quantity by Region (2018-2029)
  4.1.2 Global Antimalarial Medication Consumption Value by Region (2018-2029)
  4.1.3 Global Antimalarial Medication Average Price by Region (2018-2029)
4.2 North America Antimalarial Medication Consumption Value (2018-2029)
4.3 Europe Antimalarial Medication Consumption Value (2018-2029)
4.4 Asia-Pacific Antimalarial Medication Consumption Value (2018-2029)
4.5 South America Antimalarial Medication Consumption Value (2018-2029)
4.6 Middle East and Africa Antimalarial Medication Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Antimalarial Medication Sales Quantity by Type (2018-2029)
5.2 Global Antimalarial Medication Consumption Value by Type (2018-2029)
5.3 Global Antimalarial Medication Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Antimalarial Medication Sales Quantity by Application (2018-2029)
6.2 Global Antimalarial Medication Consumption Value by Application (2018-2029)
6.3 Global Antimalarial Medication Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Antimalarial Medication Sales Quantity by Type (2018-2029)
7.2 North America Antimalarial Medication Sales Quantity by Application (2018-2029)
7.3 North America Antimalarial Medication Market Size by Country
  7.3.1 North America Antimalarial Medication Sales Quantity by Country (2018-2029)
  7.3.2 North America Antimalarial Medication Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Antimalarial Medication Sales Quantity by Type (2018-2029)
8.2 Europe Antimalarial Medication Sales Quantity by Application (2018-2029)
8.3 Europe Antimalarial Medication Market Size by Country
  8.3.1 Europe Antimalarial Medication Sales Quantity by Country (2018-2029)
  8.3.2 Europe Antimalarial Medication Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Antimalarial Medication Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Antimalarial Medication Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Antimalarial Medication Market Size by Region
  9.3.1 Asia-Pacific Antimalarial Medication Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Antimalarial Medication Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Antimalarial Medication Sales Quantity by Type (2018-2029)
10.2 South America Antimalarial Medication Sales Quantity by Application (2018-2029)
10.3 South America Antimalarial Medication Market Size by Country
  10.3.1 South America Antimalarial Medication Sales Quantity by Country (2018-2029)
  10.3.2 South America Antimalarial Medication Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Antimalarial Medication Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Antimalarial Medication Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Antimalarial Medication Market Size by Country
  11.3.1 Middle East & Africa Antimalarial Medication Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Antimalarial Medication Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Antimalarial Medication Market Drivers
12.2 Antimalarial Medication Market Restraints
12.3 Antimalarial Medication Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Antimalarial Medication and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antimalarial Medication
13.3 Antimalarial Medication Production Process
13.4 Antimalarial Medication Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Antimalarial Medication Typical Distributors
14.3 Antimalarial Medication Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Antimalarial Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Antimalarial Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Antimalarial Medication Product and Services
Table 6. GlaxoSmithKline Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 9. F. Hoffmann-La Roche Major Business
Table 10. F. Hoffmann-La Roche Antimalarial Medication Product and Services
Table 11. F. Hoffmann-La Roche Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. F. Hoffmann-La Roche Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Antimalarial Medication Product and Services
Table 16. Novartis Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Novartis Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Antimalarial Medication Product and Services
Table 21. Pfizer Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Industries Major Business
Table 25. Sun Pharmaceutical Industries Antimalarial Medication Product and Services
Table 26. Sun Pharmaceutical Industries Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sun Pharmaceutical Industries Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Antimalarial Medication Product and Services
Table 31. Merck Antimalarial Medication Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck Recent Developments/Updates
Table 33. Global Antimalarial Medication Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Antimalarial Medication Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Antimalarial Medication Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 36. Market Position of Manufacturers in Antimalarial Medication, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Antimalarial Medication Production Site of Key Manufacturer
Table 38. Antimalarial Medication Market: Company Product Type Footprint
Table 39. Antimalarial Medication Market: Company Product Application Footprint
Table 40. Antimalarial Medication New Market Entrants and Barriers to Market Entry
Table 41. Antimalarial Medication Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Antimalarial Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Antimalarial Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Antimalarial Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Antimalarial Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Antimalarial Medication Average Price by Region (2018-2023) & (USD/Unit)
Table 47. Global Antimalarial Medication Average Price by Region (2024-2029) & (USD/Unit)
Table 48. Global Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Antimalarial Medication Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Antimalarial Medication Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Antimalarial Medication Average Price by Type (2018-2023) & (USD/Unit)
Table 53. Global Antimalarial Medication Average Price by Type (2024-2029) & (USD/Unit)
Table 54. Global Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Antimalarial Medication Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Antimalarial Medication Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Antimalarial Medication Average Price by Application (2018-2023) & (USD/Unit)
Table 59. Global Antimalarial Medication Average Price by Application (2024-2029) & (USD/Unit)
Table 60. North America Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Antimalarial Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Antimalarial Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Antimalarial Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Antimalarial Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Antimalarial Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Antimalarial Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Antimalarial Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Antimalarial Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Antimalarial Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Antimalarial Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Antimalarial Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Antimalarial Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Antimalarial Medication Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Antimalarial Medication Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Antimalarial Medication Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Antimalarial Medication Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Antimalarial Medication Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Antimalarial Medication Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Antimalarial Medication Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Antimalarial Medication Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Antimalarial Medication Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Antimalarial Medication Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Antimalarial Medication Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Antimalarial Medication Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Antimalarial Medication Raw Material
Table 101. Key Manufacturers of Antimalarial Medication Raw Materials
Table 102. Antimalarial Medication Typical Distributors
Table 103. Antimalarial Medication Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Antimalarial Medication Picture
Figure 2. Global Antimalarial Medication Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Antimalarial Medication Consumption Value Market Share by Type in 2022
Figure 4. Plasmodium Falciparum Examples
Figure 5. Plasmodium Malariae Examples
Figure 6. Plasmodium Vivax Examples
Figure 7. Plasmodium Ovale Examples
Figure 8. Global Antimalarial Medication Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Antimalarial Medication Consumption Value Market Share by Application in 2022
Figure 10. Hospital Pharmacy Examples
Figure 11. Retail Pharmacy Examples
Figure 12. E- Commerce Examples
Figure 13. Others Examples
Figure 14. Global Antimalarial Medication Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Antimalarial Medication Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Antimalarial Medication Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Antimalarial Medication Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Antimalarial Medication Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Antimalarial Medication Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Antimalarial Medication by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Antimalarial Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Antimalarial Medication Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Antimalarial Medication Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Antimalarial Medication Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Antimalarial Medication Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Antimalarial Medication Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Antimalarial Medication Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Antimalarial Medication Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Antimalarial Medication Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Antimalarial Medication Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Antimalarial Medication Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Antimalarial Medication Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Antimalarial Medication Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Antimalarial Medication Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Antimalarial Medication Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Antimalarial Medication Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Antimalarial Medication Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Antimalarial Medication Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Antimalarial Medication Consumption Value Market Share by Region (2018-2029)
Figure 56. China Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Antimalarial Medication Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Antimalarial Medication Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Antimalarial Medication Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Antimalarial Medication Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Antimalarial Medication Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Antimalarial Medication Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Antimalarial Medication Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Antimalarial Medication Market Drivers
Figure 77. Antimalarial Medication Market Restraints
Figure 78. Antimalarial Medication Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Antimalarial Medication in 2022
Figure 81. Manufacturing Process Analysis of Antimalarial Medication
Figure 82. Antimalarial Medication Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source